| ACAGT-007a, an ERK MAPK signaling modulator, in combination with AKT signaling inhibition induces apoptosis in kras mutant pancreatic cancer T3M4 and MIA-Pa-Ca-2 cells GI Khandakar, R Satoh, T Takasaki, K Fujitani, G Tanabe, K Sakai, ... Cells 11 (4), 702, 2022 | 8 | 2022 |
| ACA‐28, an ERK MAPK Signaling Modulator, Exerts Anticancer Activity through ROS Induction in Melanoma and Pancreatic Cancer Cells T Takasaki, Y Hamabe, K Touchi, GI Khandakar, T Ueda, H Okada, ... Oxidative Medicine and Cellular Longevity 2024 (1), 7683793, 2024 | 1 | 2024 |
| ACAGT‐007a, an anti‐cancer compound that modulates ERK MAPK signaling, induces nuclear enrichment of phosphorylated ERK in T3M4 pancreatic cancer cells GI Khandakar, Y Miyamoto, R Satoh, K Kishimoto, M Xie, M Shih, ... Genes to Cells 28 (6), 457-465, 2023 | | 2023 |
| ACA-28, an anticancer compound, induces Pap1 nuclear accumulation via ROS-dependent and-independent mechanisms in fission yeast T Takasaki, R Obana, D Fujiwara, N Tomimoto, GI Khandakar, R Satoh, ... Micropublication Biology 2023, 2023 | | 2023 |
| A novel therapeutic approach for pancreatic ductal adenocarcinoma treatment: Study on the role of an ERK-MAPK signaling modulator ACAGT-007a in apoptosis induction in KRAS … GI Khandakar 博士学位論文/内容の要旨および審査結果の要旨 (令和 4 年度授与), 1-5, 2022 | | 2022 |
Reiko SugiuraKindai University在 phar.kindai.ac.jp 的电子邮件经过验证
Reiko SugiuraKindai University在 phar.kindai.ac.jp 的电子邮件经过验证